APSAC in myocardial infarction
Last reviewed 01/2018
Therapeutic trials testing the efficacy of APSAC in the management of myocardial infarction include:
- ISIS-3
You are currently on the
Australia version of this site. To see content specific to your location,
please choose your country or region.
GPnotebook no longer supports Internet Explorer. To ensure the site functions as intended, please
upgrade your browser. Microsoft is encouraging users to upgrade to its more modern
Edge browser for improved security and functionality.